223 related articles for article (PubMed ID: 30760538)
1. Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
Barnabas GD; Bahar-Shany K; Sapoznik S; Helpman L; Kadan Y; Beiner M; Weitzner O; Arbib N; Korach J; Perri T; Katz G; Blecher A; Brandt B; Friedman E; Stockheim D; Jakobson-Setton A; Eitan R; Armon S; Brand H; Zadok O; Aviel-Ronen S; Harel M; Geiger T; Levanon K
Mol Cell Proteomics; 2019 May; 18(5):865-875. PubMed ID: 30760538
[TBL] [Abstract][Full Text] [Related]
2. Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
Bahar-Shany K; Barnabas GD; Deutsch L; Deutsch N; Glick-Saar E; Dominissini D; Sapoznik S; Helpman L; Perri T; Blecher A; Katz G; Yagel I; Rosenblatt O; Shai D; Brandt B; Meyer R; Mohr-Sasson A; Volodarsky-Perel A; Zilberman I; Armon S; Jakobson-Setton A; Eitan R; Kadan Y; Beiner M; Josephy D; Brodsky M; Friedman E; Anafi L; Molchanov Y; Korach J; Geiger T; Levanon K
Int J Cancer; 2023 Feb; 152(4):781-793. PubMed ID: 36214786
[TBL] [Abstract][Full Text] [Related]
3. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
4. RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer.
Hulstaert E; Levanon K; Morlion A; Van Aelst S; Christidis AA; Zamar R; Anckaert J; Verniers K; Bahar-Shany K; Sapoznik S; Vandesompele J; Mestdagh P
Neoplasia; 2022 Feb; 24(2):155-164. PubMed ID: 34998206
[TBL] [Abstract][Full Text] [Related]
5. Feature selection and nearest centroid classification for protein mass spectrometry.
Levner I
BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
[TBL] [Abstract][Full Text] [Related]
6. Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study.
Maritschnegg E; Heitz F; Pecha N; Bouda J; Trillsch F; Grimm C; Vanderstichele A; Agreiter C; Harter P; Obermayr E; Vergote I; Zeillinger R; Speiser P
Int J Gynecol Cancer; 2018 Nov; 28(9):1692-1698. PubMed ID: 30376484
[TBL] [Abstract][Full Text] [Related]
7. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
8. Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2.
Marcišauskas S; Ulfenborg B; Kristjansdottir B; Waldemarson S; Sundfeldt K
J Proteomics; 2019 Mar; 196():57-68. PubMed ID: 30710757
[TBL] [Abstract][Full Text] [Related]
9. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
10. Data mining techniques for cancer detection using serum proteomic profiling.
Li L; Tang H; Wu Z; Gong J; Gruidl M; Zou J; Tockman M; Clark RA
Artif Intell Med; 2004 Oct; 32(2):71-83. PubMed ID: 15364092
[TBL] [Abstract][Full Text] [Related]
11. Translational Research and Plasma Proteomic in Cancer.
Santini AC; Giovane G; Auletta A; Di Carlo A; Fiorelli A; Cito L; Astarita C; Giordano A; Alfano R; Feola A; Di Domenico M
J Cell Biochem; 2016 Apr; 117(4):828-35. PubMed ID: 26479787
[TBL] [Abstract][Full Text] [Related]
12. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.
Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L
BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling in ovarian cancer.
Kim G; Minig L; Kohn EC
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2(Suppl 2):S2-6. PubMed ID: 19955909
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis.
Xiao Y; Bi M; Guo H; Li M
EBioMedicine; 2022 May; 79():104001. PubMed ID: 35439677
[TBL] [Abstract][Full Text] [Related]
15. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B
Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer.
Zheng X; Li X; Wang X
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188395. PubMed ID: 32698041
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
Ryu J; Thomas SN
Molecules; 2021 May; 26(9):. PubMed ID: 34063568
[TBL] [Abstract][Full Text] [Related]
18. An overview of biomarkers for the ovarian cancer diagnosis.
Zhang B; Cai FF; Zhong XY
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
[TBL] [Abstract][Full Text] [Related]
19. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
Stevens EV; Liotta LA; Kohn EC
Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]